microRNA information: hsa-miR-146b-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-146b-3p | miRbase |
Accession: | MIMAT0004766 | miRbase |
Precursor name: | hsa-mir-146b | miRbase |
Precursor accession: | MI0003129 | miRbase |
Symbol: | MIR146B | HGNC |
RefSeq ID: | NR_030169 | GenBank |
Sequence: | UGCCCUGUGGACUCAGUUCUGG |
Reported expression in cancers: hsa-miR-146b-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-146b-3p | bladder cancer | deregulation | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | qPCR |
hsa-miR-146b-3p | breast cancer | downregulation | "Associations of miR 146a and miR 146b expression a ......" | 26406414 | |
hsa-miR-146b-3p | esophageal cancer | upregulation | "Recent clinical study indicated that up-regulation ......" | 24589738 | |
hsa-miR-146b-3p | lung cancer | deregulation | "Microarray studies revealed alterations in the exp ......" | 19748927 | Microarray; Reverse transcription PCR |
hsa-miR-146b-3p | lung squamous cell cancer | upregulation | "Furthermore we detected the expression of miR-146 ......" | 24448024 | |
hsa-miR-146b-3p | melanoma | deregulation | "An exploratory miRNA analysis of 666 miRs by low d ......" | 20302635 | Microarray |
hsa-miR-146b-3p | prostate cancer | upregulation | "Loss of 18 miRNAs e.g.miR-34c miR-29b miR-212 and ......" | 23781281 | |
hsa-miR-146b-3p | prostate cancer | downregulation | "MicroRNA 146b acts as a potential tumor suppressor ......" | 27273955 | qPCR |
hsa-miR-146b-3p | thyroid cancer | upregulation | "miR 146b is highly expressed in adult papillary th ......" | 20406109 | qPCR |
hsa-miR-146b-3p | thyroid cancer | upregulation | "Prognostic implications of miR 146b expression and ......" | 23264400 | qPCR |
hsa-miR-146b-3p | thyroid cancer | upregulation | "The aim of this study was to assess miRNA expressi ......" | 23427895 | Microarray |
hsa-miR-146b-3p | thyroid cancer | upregulation | "To detect the levels of miRNA expression in fresh ......" | 23569392 | Microarray |
hsa-miR-146b-3p | thyroid cancer | upregulation | "Associations of miR 146a and miR 146b expression a ......" | 25524940 | |
hsa-miR-146b-3p | thyroid cancer | upregulation | "We hypothesized that the culpable mechanisms inclu ......" | 27011326 |
Reported cancer pathway affected by hsa-miR-146b-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-146b-3p | cervical and endocervical cancer | cell cycle pathway | "Inhibitory effect and mechanisms of microRNA 146b ......" | 25572123 | Flow cytometry; Transwell assay; Western blot |
hsa-miR-146b-3p | esophageal cancer | Apoptosis pathway | "Transcriptional regulation of miR 146b by C/EBPβ ......" | 24589738 | |
hsa-miR-146b-3p | prostate cancer | Apoptosis pathway | "MicroRNA 146b acts as a potential tumor suppressor ......" | 27273955 | |
hsa-miR-146b-3p | thyroid cancer | Apoptosis pathway | "Prognostic implications of miR 146b expression and ......" | 23264400 | Colony formation |
hsa-miR-146b-3p | thyroid cancer | Apoptosis pathway | "A miR-microarray study was conducted to identify m ......" | 24631480 | |
hsa-miR-146b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "The roles of the epithelial mesenchymal transition ......" | 24946010 | |
hsa-miR-146b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "MiR 146b 5p promotes metastasis and induces epithe ......" | 25547151 | |
hsa-miR-146b-3p | thyroid cancer | cell cycle pathway | "p21 participates in the regulation of anaplastic t ......" | 27602131 |
Reported cancer prognosis affected by hsa-miR-146b-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-146b-3p | bladder cancer | staging | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | |
hsa-miR-146b-3p | bladder cancer | drug resistance | "Focusing on the major obstacle regarding MIBC pati ......" | 27586262 | |
hsa-miR-146b-3p | breast cancer | metastasis | "Breast cancer metastasis suppressor 1 up regulates ......" | 19190326 | |
hsa-miR-146b-3p | breast cancer | differentiation | "In order to identify which miRNAs are involved in ......" | 22562546 | |
hsa-miR-146b-3p | cervical and endocervical cancer | progression | "Inhibitory effect and mechanisms of microRNA 146b ......" | 25572123 | Flow cytometry; Transwell assay; Western blot |
hsa-miR-146b-3p | esophageal cancer | poor survival | "The expression levels of miR-21 p = 0.027 miR-181b ......" | 23175214 | |
hsa-miR-146b-3p | esophageal cancer | poor survival | "Transcriptional regulation of miR 146b by C/EBPβ ......" | 24589738 | |
hsa-miR-146b-3p | kidney renal cell cancer | metastasis | "Integrated microRNA and mRNA Signature Associated ......" | 26859141 | |
hsa-miR-146b-3p | lung cancer | malignant trasformation; recurrence | "Overexpression of the lung cancer prognostic miR 1 ......" | 21789255 | Colony formation |
hsa-miR-146b-3p | lung cancer | tumorigenesis | "Other significantly differentiated miR families in ......" | 23035181 | |
hsa-miR-146b-3p | lung squamous cell cancer | worse prognosis | "In this study we first identified microRNA146 miR- ......" | 24448024 | |
hsa-miR-146b-3p | melanoma | progression | "However miR-146a levels drop in Circulating Tumor ......" | 26965144 | |
hsa-miR-146b-3p | pancreatic cancer | cell migration | "Inhibitory effects of miR 146b 5p on cell migratio ......" | 21823013 | |
hsa-miR-146b-3p | pancreatic cancer | staging | "At 25 weeks the miRNA microarray analysis revealed ......" | 26516699 | |
hsa-miR-146b-3p | prostate cancer | recurrence; progression | "MicroRNAs in the serum of patients who had experie ......" | 23846169 | |
hsa-miR-146b-3p | sarcoma | metastasis; drug resistance | "miR 146b 5p promotes invasion and metastasis contr ......" | 26549292 | |
hsa-miR-146b-3p | thyroid cancer | tumorigenesis | "MicroRNA miRNA microarray analysis has consistentl ......" | 18587330 | |
hsa-miR-146b-3p | thyroid cancer | metastasis; recurrence | "In this study we evaluated miRNA expression as a m ......" | 21537871 | |
hsa-miR-146b-3p | thyroid cancer | staging; worse prognosis; cell migration; metastasis; poor survival; drug resistance | "Prognostic implications of miR 146b expression and ......" | 23264400 | Colony formation |
hsa-miR-146b-3p | thyroid cancer | tumor size; staging; metastasis | "To detect the levels of miRNA expression in fresh ......" | 23569392 | |
hsa-miR-146b-3p | thyroid cancer | recurrence | "MicroRNA 222 and microRNA 146b are tissue and circ ......" | 24301304 | |
hsa-miR-146b-3p | thyroid cancer | progression | "The roles of the epithelial mesenchymal transition ......" | 24946010 | |
hsa-miR-146b-3p | thyroid cancer | tumorigenesis | "Upregulation of miRNAs such as miR-146b miR-221 an ......" | 25202329 | |
hsa-miR-146b-3p | thyroid cancer | tumor size; malignant trasformation | "Differential expression levels of plasma derived m ......" | 25456009 | |
hsa-miR-146b-3p | thyroid cancer | staging; tumorigenesis | "Associations of miR 146a and miR 146b expression a ......" | 25524940 | |
hsa-miR-146b-3p | thyroid cancer | metastasis | "MiR 146b 5p promotes metastasis and induces epithe ......" | 25547151 | |
hsa-miR-146b-3p | thyroid cancer | recurrence | "In the present study we investigated whether miR-9 ......" | 26007293 | |
hsa-miR-146b-3p | thyroid cancer | tumor size | "All tumors were tested for the presence of the BRA ......" | 26950846 | |
hsa-miR-146b-3p | thyroid cancer | staging; worse prognosis | "IRAK1 a Target of miR 146b Reduces Cell Aggressive ......" | 27533309 | Colony formation |
hsa-miR-146b-3p | thyroid cancer | cell migration; progression | "p21 participates in the regulation of anaplastic t ......" | 27602131 |
Reported gene related to hsa-miR-146b-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-146b-3p | thyroid cancer | BRAF | "The miR-146b expression levels in PTCs with BRAF m ......" | 20406109 |
hsa-miR-146b-3p | thyroid cancer | BRAF | "Among BRAF-positive tumors overexpression of miR-1 ......" | 21537871 |
hsa-miR-146b-3p | thyroid cancer | ATM | "The role of microRNA 146b miR-146b in ATC remains ......" | 27602131 |
hsa-miR-146b-3p | breast cancer | BRMS1 | "BRMS1 significantly up-regulates miR-146a by 6- to ......" | 19190326 |
hsa-miR-146b-3p | colorectal cancer | CASR | "miR 135b and miR 146b dependent silencing of calci ......" | 26178670 |
hsa-miR-146b-3p | thyroid cancer | CDKN1A | "During the search for potential targets of miR-146 ......" | 27602131 |
hsa-miR-146b-3p | breast cancer | IL6 | "We investigated expressions of miR-146a miR-146b a ......" | 26406414 |
hsa-miR-146b-3p | thyroid cancer | IRAK1 | "IRAK1 a Target of miR 146b Reduces Cell Aggressive ......" | 27533309 |
hsa-miR-146b-3p | pancreatic cancer | MIA | "The present study identifies a series of miRNAs wh ......" | 23073476 |
hsa-miR-146b-3p | pancreatic cancer | MMP16 | "Inhibitory effects of miR 146b 5p on cell migratio ......" | 21823013 |
hsa-miR-146b-3p | breast cancer | MTSS1 | "Breast cancer metastasis suppressor 1 up regulates ......" | 19190326 |
hsa-miR-146b-3p | breast cancer | NFKB1 | "Extending observations from an immunologic setting ......" | 18504431 |
hsa-miR-146b-3p | gastric cancer | NOVA1 | "NOVA1 inhibition by miR 146b 5p in the remnant tis ......" | 26673617 |
hsa-miR-146b-3p | thyroid cancer | PRRX1 | "The roles of the epithelial mesenchymal transition ......" | 24946010 |
hsa-miR-146b-3p | lymphoma | PTLS | "Significant down-regulation of hsa-miR-26a was obs ......" | 24327568 |
hsa-miR-146b-3p | thyroid cancer | SLC5A5 | "Inhibition of miR 146b expression increases radioi ......" | 25960292 |
hsa-miR-146b-3p | thyroid cancer | SMAD4 | "MicroRNA miR 146b 5p regulates signal transduction ......" | 21874046 |
hsa-miR-146b-3p | gastric cancer | UHRF1 | "We identified and verified miR-146a and miR-146b a ......" | 23982143 |
hsa-miR-146b-3p | thyroid cancer | ZNRF3 | "MiR 146b 5p promotes metastasis and induces epithe ......" | 25547151 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-146b-3p | UST | 9 cancers: BLCA; CESC; HNSC; KIRC; LGG; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.365; TCGA CESC -0.323; TCGA HNSC -0.192; TCGA KIRC -0.182; TCGA LGG -0.328; TCGA LUSC -0.141; TCGA PRAD -0.104; TCGA THCA -0.133; TCGA STAD -0.405 |
hsa-miR-146b-3p | NCKAP5 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.222; TCGA BRCA -0.144; TCGA CESC -0.254; TCGA HNSC -0.204; TCGA KIRC -0.101; TCGA LGG -0.129; TCGA THCA -0.112; TCGA STAD -0.176; TCGA UCEC -0.142 |
hsa-miR-146b-3p | FAM84A | 9 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; SARC; UCEC | MirTarget | TCGA BLCA -0.642; TCGA CESC -0.422; TCGA COAD -0.261; TCGA HNSC -0.438; TCGA LUAD -0.365; TCGA LUSC -0.723; TCGA PAAD -0.233; TCGA SARC -0.323; TCGA UCEC -0.309 |
hsa-miR-146b-3p | PLXNA2 | 9 cancers: BLCA; COAD; ESCA; KIRP; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.192; TCGA COAD -0.164; TCGA ESCA -0.355; TCGA KIRP -0.115; TCGA PAAD -0.232; TCGA PRAD -0.138; TCGA SARC -0.161; TCGA STAD -0.141; TCGA UCEC -0.221 |
hsa-miR-146b-3p | APBA1 | 11 cancers: BLCA; CESC; COAD; KIRC; LIHC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.269; TCGA CESC -0.246; TCGA COAD -0.162; TCGA KIRC -0.087; TCGA LIHC -0.127; TCGA OV -0.209; TCGA PAAD -0.181; TCGA SARC -0.214; TCGA THCA -0.087; TCGA STAD -0.243; TCGA UCEC -0.332 |
hsa-miR-146b-3p | REPS2 | 9 cancers: BLCA; BRCA; COAD; ESCA; LGG; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.17; TCGA BRCA -0.411; TCGA COAD -0.269; TCGA ESCA -0.465; TCGA LGG -0.17; TCGA SARC -0.163; TCGA THCA -0.082; TCGA STAD -0.212; TCGA UCEC -0.307 |
hsa-miR-146b-3p | CPEB4 | 9 cancers: BLCA; BRCA; ESCA; KIRC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.065; TCGA BRCA -0.215; TCGA ESCA -0.196; TCGA KIRC -0.201; TCGA PRAD -0.086; TCGA SARC -0.248; TCGA THCA -0.131; TCGA STAD -0.189; TCGA UCEC -0.198 |
hsa-miR-146b-3p | B3GALT5 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.553; TCGA CESC -0.437; TCGA ESCA -0.694; TCGA LUAD -0.363; TCGA LUSC -0.618; TCGA SARC -0.391; TCGA THCA -0.248; TCGA STAD -0.269; TCGA UCEC -0.286 |
hsa-miR-146b-3p | WDFY3 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.22; TCGA BRCA -0.142; TCGA CESC -0.097; TCGA ESCA -0.11; TCGA HNSC -0.082; TCGA KIRC -0.106; TCGA LGG -0.071; TCGA SARC -0.057; TCGA STAD -0.119; TCGA UCEC -0.108 |
hsa-miR-146b-3p | GAS2 | 11 cancers: BLCA; COAD; KIRC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; PITA | TCGA BLCA -0.433; TCGA COAD -0.611; TCGA KIRC -0.187; TCGA KIRP -0.139; TCGA LUAD -0.239; TCGA OV -0.208; TCGA PAAD -0.217; TCGA PRAD -0.112; TCGA THCA -0.095; TCGA STAD -0.198; TCGA UCEC -0.409 |
hsa-miR-146b-3p | USP8 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; UCEC | MirTarget; PITA | TCGA BLCA -0.1; TCGA BRCA -0.114; TCGA ESCA -0.092; TCGA HNSC -0.064; TCGA KIRC -0.092; TCGA KIRP -0.074; TCGA LUAD -0.065; TCGA PRAD -0.075; TCGA SARC -0.058; TCGA UCEC -0.053 |
hsa-miR-146b-3p | EFCAB6 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.398; TCGA BRCA -0.389; TCGA COAD -0.257; TCGA HNSC -0.218; TCGA KIRC -0.065; TCGA PAAD -0.324; TCGA SARC -0.175; TCGA THCA -0.089; TCGA STAD -0.375; TCGA UCEC -0.248 |
hsa-miR-146b-3p | PTCHD1 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.712; TCGA CESC -0.575; TCGA ESCA -0.507; TCGA HNSC -0.296; TCGA KIRP -0.259; TCGA OV -0.292; TCGA PRAD -0.388; TCGA SARC -0.983; TCGA STAD -1.098; TCGA UCEC -0.368 |
hsa-miR-146b-3p | SORT1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; PRAD; SARC; STAD | MirTarget; PITA; miRNATAP | TCGA BLCA -0.082; TCGA BRCA -0.154; TCGA CESC -0.221; TCGA COAD -0.142; TCGA ESCA -0.286; TCGA HNSC -0.217; TCGA KIRC -0.168; TCGA PRAD -0.089; TCGA SARC -0.272; TCGA STAD -0.148 |
hsa-miR-146b-3p | PRKAA1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; SARC; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.096; TCGA CESC -0.102; TCGA COAD -0.102; TCGA ESCA -0.16; TCGA HNSC -0.076; TCGA KIRP -0.056; TCGA LUAD -0.138; TCGA SARC -0.184; TCGA UCEC -0.075 |
hsa-miR-146b-3p | ZNF219 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD | PITA | TCGA BLCA -0.278; TCGA BRCA -0.104; TCGA CESC -0.112; TCGA ESCA -0.165; TCGA HNSC -0.118; TCGA KIRC -0.075; TCGA LGG -0.265; TCGA LIHC -0.155; TCGA LUSC -0.154; TCGA PAAD -0.24; TCGA PRAD -0.194; TCGA SARC -0.22; TCGA THCA -0.057; TCGA STAD -0.192 |
hsa-miR-146b-3p | GOT2 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | PITA | TCGA BLCA -0.134; TCGA BRCA -0.137; TCGA COAD -0.075; TCGA HNSC -0.084; TCGA KIRC -0.129; TCGA LUAD -0.082; TCGA LUSC -0.303; TCGA PAAD -0.104; TCGA PRAD -0.107; TCGA THCA -0.082 |
hsa-miR-146b-3p | TEF | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; STAD; UCEC | PITA | TCGA BLCA -0.146; TCGA BRCA -0.151; TCGA CESC -0.146; TCGA ESCA -0.2; TCGA HNSC -0.161; TCGA KIRC -0.288; TCGA KIRP -0.18; TCGA LGG -0.069; TCGA LIHC -0.099; TCGA PAAD -0.149; TCGA PRAD -0.165; TCGA SARC -0.198; TCGA STAD -0.412; TCGA UCEC -0.14 |
hsa-miR-146b-3p | RALGPS1 | 14 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; OV; PAAD; SARC; THCA; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.414; TCGA BRCA -0.284; TCGA CESC -0.227; TCGA ESCA -0.424; TCGA KIRC -0.411; TCGA KIRP -0.159; TCGA LGG -0.09; TCGA LIHC -0.132; TCGA OV -0.13; TCGA PAAD -0.461; TCGA SARC -0.23; TCGA THCA -0.102; TCGA STAD -0.075; TCGA UCEC -0.098 |
hsa-miR-146b-3p | CAMK2N1 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; OV; PAAD; PRAD; STAD; UCEC | PITA | TCGA BLCA -0.447; TCGA BRCA -0.228; TCGA COAD -0.22; TCGA KIRC -0.12; TCGA KIRP -0.112; TCGA OV -0.221; TCGA PAAD -0.159; TCGA PRAD -0.108; TCGA STAD -0.163; TCGA UCEC -0.306 |
hsa-miR-146b-3p | ZSWIM5 | 9 cancers: BLCA; BRCA; COAD; ESCA; LGG; PAAD; PRAD; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.422; TCGA BRCA -0.406; TCGA COAD -0.191; TCGA ESCA -0.383; TCGA LGG -0.189; TCGA PAAD -0.238; TCGA PRAD -0.103; TCGA STAD -0.244; TCGA UCEC -0.444 |
hsa-miR-146b-3p | PLEKHH3 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; SARC; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.301; TCGA BRCA -0.146; TCGA ESCA -0.153; TCGA HNSC -0.129; TCGA LGG -0.131; TCGA LIHC -0.104; TCGA LUSC -0.304; TCGA PAAD -0.274; TCGA SARC -0.096; TCGA STAD -0.134; TCGA UCEC -0.114 |
hsa-miR-146b-3p | HDHD2 | 9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; PAAD; PRAD; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.168; TCGA ESCA -0.162; TCGA KIRC -0.135; TCGA KIRP -0.065; TCGA PAAD -0.185; TCGA PRAD -0.065; TCGA STAD -0.127; TCGA UCEC -0.067 |
hsa-miR-146b-3p | ICA1L | 9 cancers: BLCA; BRCA; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | PITA | TCGA BLCA -0.251; TCGA BRCA -0.208; TCGA LGG -0.069; TCGA LUSC -0.117; TCGA PAAD -0.206; TCGA PRAD -0.148; TCGA SARC -0.255; TCGA STAD -0.373; TCGA UCEC -0.19 |
hsa-miR-146b-3p | OXR1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | PITA | TCGA BLCA -0.162; TCGA BRCA -0.058; TCGA CESC -0.11; TCGA COAD -0.221; TCGA ESCA -0.149; TCGA HNSC -0.134; TCGA KIRP -0.087; TCGA LUAD -0.067; TCGA LUSC -0.081; TCGA PRAD -0.094; TCGA SARC -0.128; TCGA STAD -0.171; TCGA UCEC -0.157 |
hsa-miR-146b-3p | CBFA2T2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA | mirMAP | TCGA BLCA -0.167; TCGA BRCA -0.12; TCGA CESC -0.249; TCGA COAD -0.207; TCGA HNSC -0.095; TCGA KIRC -0.052; TCGA LIHC -0.193; TCGA LUAD -0.08; TCGA LUSC -0.273; TCGA OV -0.081; TCGA PAAD -0.262; TCGA SARC -0.113; TCGA THCA -0.052 |
hsa-miR-146b-3p | PCYT2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD | mirMAP | TCGA BLCA -0.165; TCGA BRCA -0.082; TCGA ESCA -0.187; TCGA HNSC -0.162; TCGA KIRC -0.211; TCGA LUAD -0.108; TCGA LUSC -0.196; TCGA OV -0.128; TCGA PAAD -0.225 |
hsa-miR-146b-3p | PPARA | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.103; TCGA CESC -0.104; TCGA COAD -0.095; TCGA ESCA -0.194; TCGA HNSC -0.117; TCGA KIRC -0.214; TCGA KIRP -0.074; TCGA LGG -0.06; TCGA LUSC -0.087; TCGA PRAD -0.102; TCGA SARC -0.135; TCGA STAD -0.14 |
hsa-miR-146b-3p | TSTD1 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; OV; PAAD; PRAD | miRNATAP | TCGA BLCA -0.104; TCGA BRCA -0.289; TCGA COAD -0.196; TCGA HNSC -0.289; TCGA KIRC -0.151; TCGA KIRP -0.07; TCGA OV -0.1; TCGA PAAD -0.412; TCGA PRAD -0.077 |
hsa-miR-146b-3p | MAPT | 10 cancers: BLCA; BRCA; LGG; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.269; TCGA BRCA -0.777; TCGA LGG -0.237; TCGA LIHC -0.267; TCGA PAAD -0.37; TCGA PRAD -0.133; TCGA SARC -0.433; TCGA THCA -0.241; TCGA STAD -0.628; TCGA UCEC -0.189 |
hsa-miR-146b-3p | LLGL2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD | miRNATAP | TCGA BLCA -0.261; TCGA BRCA -0.115; TCGA COAD -0.099; TCGA ESCA -0.331; TCGA HNSC -0.24; TCGA KIRC -0.324; TCGA KIRP -0.119; TCGA LIHC -0.123; TCGA LUAD -0.116; TCGA OV -0.13; TCGA PAAD -0.427 |
hsa-miR-146b-3p | LSM14B | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD | miRNATAP | TCGA BLCA -0.068; TCGA BRCA -0.079; TCGA CESC -0.13; TCGA COAD -0.17; TCGA HNSC -0.094; TCGA LIHC -0.089; TCGA LUAD -0.089; TCGA LUSC -0.29; TCGA PAAD -0.206 |
hsa-miR-146b-3p | CDAN1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; SARC | miRNATAP | TCGA BLCA -0.139; TCGA BRCA -0.113; TCGA HNSC -0.056; TCGA KIRC -0.052; TCGA KIRP -0.09; TCGA LGG -0.145; TCGA LIHC -0.104; TCGA LUSC -0.261; TCGA PAAD -0.074; TCGA SARC -0.063 |
hsa-miR-146b-3p | PARD6A | 10 cancers: BLCA; BRCA; ESCA; KIRC; LGG; LUAD; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.185; TCGA BRCA -0.206; TCGA ESCA -0.37; TCGA KIRC -0.193; TCGA LGG -0.078; TCGA LUAD -0.165; TCGA PAAD -0.346; TCGA SARC -0.111; TCGA THCA -0.07; TCGA STAD -0.089 |
hsa-miR-146b-3p | ZBTB4 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.126; TCGA BRCA -0.166; TCGA KIRC -0.131; TCGA KIRP -0.055; TCGA LIHC -0.07; TCGA PRAD -0.125; TCGA SARC -0.108; TCGA STAD -0.247; TCGA UCEC -0.166 |
hsa-miR-146b-3p | GBA2 | 11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; OV; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.094; TCGA BRCA -0.105; TCGA ESCA -0.233; TCGA KIRC -0.212; TCGA KIRP -0.094; TCGA LIHC -0.069; TCGA OV -0.071; TCGA PAAD -0.255; TCGA SARC -0.091; TCGA THCA -0.083; TCGA STAD -0.078 |
hsa-miR-146b-3p | CACNB2 | 10 cancers: BLCA; BRCA; KIRC; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.317; TCGA BRCA -0.292; TCGA KIRC -0.223; TCGA LIHC -0.122; TCGA PAAD -0.422; TCGA PRAD -0.169; TCGA SARC -0.46; TCGA THCA -0.197; TCGA STAD -0.51; TCGA UCEC -0.369 |
hsa-miR-146b-3p | CBX7 | 10 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.251; TCGA BRCA -0.096; TCGA ESCA -0.233; TCGA KIRC -0.187; TCGA KIRP -0.129; TCGA PAAD -0.189; TCGA PRAD -0.154; TCGA SARC -0.414; TCGA STAD -0.447; TCGA UCEC -0.265 |
hsa-miR-146b-3p | UBN2 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUSC; PAAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.255; TCGA BRCA -0.155; TCGA CESC -0.074; TCGA COAD -0.148; TCGA HNSC -0.117; TCGA LGG -0.149; TCGA LIHC -0.097; TCGA LUSC -0.208; TCGA PAAD -0.165; TCGA SARC -0.105; TCGA THCA -0.069; TCGA UCEC -0.094 |
hsa-miR-146b-3p | USP46 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; THCA; STAD | miRNATAP | TCGA BLCA -0.137; TCGA BRCA -0.094; TCGA CESC -0.108; TCGA ESCA -0.14; TCGA HNSC -0.2; TCGA KIRC -0.156; TCGA KIRP -0.083; TCGA LIHC -0.074; TCGA LUAD -0.075; TCGA LUSC -0.265; TCGA THCA -0.084; TCGA STAD -0.069 |
hsa-miR-146b-3p | PLCD1 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.365; TCGA CESC -0.173; TCGA COAD -0.117; TCGA HNSC -0.243; TCGA KIRC -0.183; TCGA PRAD -0.102; TCGA SARC -0.081; TCGA STAD -0.275; TCGA UCEC -0.091 |
hsa-miR-146b-3p | RAP1GAP | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; THCA | miRNATAP | TCGA BLCA -0.526; TCGA BRCA -0.16; TCGA ESCA -0.542; TCGA HNSC -0.474; TCGA KIRC -0.574; TCGA KIRP -0.265; TCGA LUAD -0.161; TCGA PAAD -0.367; TCGA THCA -0.327 |
hsa-miR-146b-3p | TET2 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; UCEC | miRNATAP | TCGA BLCA -0.201; TCGA BRCA -0.058; TCGA CESC -0.172; TCGA HNSC -0.148; TCGA KIRC -0.052; TCGA LGG -0.158; TCGA LUAD -0.059; TCGA LUSC -0.114; TCGA UCEC -0.142 |
hsa-miR-146b-3p | TIMM17B | 9 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNATAP | TCGA BLCA -0.054; TCGA BRCA -0.117; TCGA COAD -0.203; TCGA LGG -0.076; TCGA LIHC -0.074; TCGA LUAD -0.134; TCGA LUSC -0.252; TCGA PAAD -0.274; TCGA THCA -0.155 |
hsa-miR-146b-3p | CXorf23 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.146; TCGA BRCA -0.128; TCGA CESC -0.091; TCGA COAD -0.206; TCGA KIRP -0.068; TCGA LIHC -0.146; TCGA SARC -0.12; TCGA STAD -0.071; TCGA UCEC -0.147 |
hsa-miR-146b-3p | PPM1A | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.192; TCGA CESC -0.137; TCGA COAD -0.091; TCGA ESCA -0.117; TCGA HNSC -0.102; TCGA KIRC -0.175; TCGA LUAD -0.073; TCGA PAAD -0.104; TCGA SARC -0.094; TCGA STAD -0.2; TCGA UCEC -0.082 |
hsa-miR-146b-3p | FSTL4 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.89; TCGA BRCA -0.567; TCGA CESC -0.42; TCGA HNSC -0.528; TCGA KIRC -0.683; TCGA LUAD -0.311; TCGA LUSC -0.676; TCGA PAAD -0.69; TCGA PRAD -0.23; TCGA SARC -0.235; TCGA STAD -0.453 |
hsa-miR-146b-3p | TMLHE | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; STAD | MirTarget | TCGA BRCA -0.054; TCGA COAD -0.234; TCGA HNSC -0.053; TCGA KIRC -0.107; TCGA KIRP -0.056; TCGA LGG -0.107; TCGA LUSC -0.132; TCGA PRAD -0.147; TCGA STAD -0.063 |
hsa-miR-146b-3p | MORF4L2 | 9 cancers: BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; SARC | MirTarget; PITA; miRNATAP | TCGA BRCA -0.15; TCGA CESC -0.085; TCGA COAD -0.087; TCGA HNSC -0.087; TCGA LIHC -0.053; TCGA LUAD -0.115; TCGA LUSC -0.144; TCGA PAAD -0.063; TCGA SARC -0.086 |
hsa-miR-146b-3p | KANK2 | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.094; TCGA CESC -0.167; TCGA ESCA -0.222; TCGA KIRC -0.068; TCGA KIRP -0.106; TCGA LIHC -0.203; TCGA PRAD -0.087; TCGA SARC -0.378; TCGA STAD -0.424; TCGA UCEC -0.224 |
hsa-miR-146b-3p | CNTNAP2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; SARC; THCA; UCEC | PITA; miRNATAP | TCGA BRCA -0.296; TCGA HNSC -0.394; TCGA KIRC -0.269; TCGA KIRP -0.237; TCGA LUAD -0.406; TCGA LUSC -1.361; TCGA SARC -0.519; TCGA THCA -0.403; TCGA UCEC -0.27 |
hsa-miR-146b-3p | THRA | 13 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; STAD; UCEC | PITA; miRNATAP | TCGA BRCA -0.182; TCGA CESC -0.22; TCGA COAD -0.192; TCGA ESCA -0.191; TCGA KIRC -0.217; TCGA KIRP -0.106; TCGA LGG -0.232; TCGA LIHC -0.118; TCGA PAAD -0.24; TCGA PRAD -0.122; TCGA SARC -0.196; TCGA STAD -0.164; TCGA UCEC -0.17 |
hsa-miR-146b-3p | SERTAD4 | 9 cancers: CESC; HNSC; KIRC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; PITA | TCGA CESC -0.579; TCGA HNSC -0.247; TCGA KIRC -0.123; TCGA LUSC -0.321; TCGA PRAD -0.202; TCGA SARC -0.377; TCGA THCA -0.058; TCGA STAD -0.571; TCGA UCEC -0.578 |
hsa-miR-146b-3p | HAP1 | 10 cancers: HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD | PITA | TCGA HNSC -0.21; TCGA KIRC -0.519; TCGA KIRP -0.208; TCGA LUAD -0.233; TCGA LUSC -1.353; TCGA OV -0.259; TCGA PAAD -0.402; TCGA PRAD -0.198; TCGA THCA -0.48; TCGA STAD -0.318 |
hsa-miR-146b-3p | NTN1 | 9 cancers: KIRC; KIRP; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA KIRC -0.413; TCGA KIRP -0.298; TCGA LGG -0.142; TCGA LUSC -0.396; TCGA PRAD -0.123; TCGA SARC -0.524; TCGA THCA -0.157; TCGA STAD -0.607; TCGA UCEC -0.186 |
Enriched cancer pathways of putative targets